109 related articles for article (PubMed ID: 12880274)
1. CD8+ T lymphocytes required for enhanced survival of Trypanosoma cruzi-infected mice at elevated environmental temperature.
Ming Z; Davis CD
J Parasitol; 2003 Jun; 89(3):630-2. PubMed ID: 12880274
[TBL] [Abstract][Full Text] [Related]
2. Endogenous CD4(+) CD25(+) regulatory T cells have a limited role in the control of Trypanosoma cruzi infection in mice.
Kotner J; Tarleton R
Infect Immun; 2007 Feb; 75(2):861-9. PubMed ID: 17101658
[TBL] [Abstract][Full Text] [Related]
3. Depletion of CD8+ T cells increases susceptibility and reverses vaccine-induced immunity in mice infected with Trypanosoma cruzi.
Tarleton RL
J Immunol; 1990 Jan; 144(2):717-24. PubMed ID: 2104903
[TBL] [Abstract][Full Text] [Related]
4. Trypanosoma cruzi: roles for perforin-dependent and perforin-independent immune mechanisms in acute resistance.
Nickell SP; Sharma D
Exp Parasitol; 2000 Apr; 94(4):207-16. PubMed ID: 10831388
[TBL] [Abstract][Full Text] [Related]
5. Antibody response to heat shock proteins and histopathology in mice infected with Trypanosoma cruzi and maintained at elevated temperature.
Arif AA; Gao L; Davis CD; Helm DS
J Parasitol; 1999 Dec; 85(6):1089-99. PubMed ID: 10647042
[TBL] [Abstract][Full Text] [Related]
6. Effect of elevated environmental temperature on the antibody response of mice to Trypanosoma cruzi during the acute phase of infection.
Dimock KA; Davis CD; Kuhn RE
Infect Immun; 1991 Dec; 59(12):4377-82. PubMed ID: 1937796
[TBL] [Abstract][Full Text] [Related]
7. Production and characterization of clones of the Brazil strain of Trypanosoma cruzi.
Murfin DJ; Choromanski L; Kuhn RE
J Parasitol; 1985 Oct; 71(5):525-9. PubMed ID: 3932632
[TBL] [Abstract][Full Text] [Related]
8. Trypanosoma cruzi: Immunological predictors of benznidazole efficacy during experimental infection.
Fernández MC; González Cappa SM; Solana ME
Exp Parasitol; 2010 Feb; 124(2):172-80. PubMed ID: 19747482
[TBL] [Abstract][Full Text] [Related]
9. Protective immunity against trypanosoma cruzi infection in a highly susceptible mouse strain after vaccination with genes encoding the amastigote surface protein-2 and trans-sialidase.
Vasconcelos JR; Hiyane MI; Marinho CR; Claser C; Machado AM; Gazzinelli RT; Bruña-Romero O; Alvarez JM; Boscardin SB; Rodrigues MM
Hum Gene Ther; 2004 Sep; 15(9):878-86. PubMed ID: 15353042
[TBL] [Abstract][Full Text] [Related]
10. Corpus Christi strain-induced protection to Trypanosoma cruzi infection in C3H(He) mice: transfer of resistance to Brazil strain challenge with lymphocytes.
Rowland EC; Ritter DM
J Parasitol; 1984 Oct; 70(5):760-6. PubMed ID: 6439846
[TBL] [Abstract][Full Text] [Related]
11. Experimental infection with Trypanosoma cruzi increases the population of CD8(+), but not CD4(+), immunoglobulin G Fc receptor-positive T lymphocytes.
Henriques-Pons A; Olivieri BP; Oliveira GM; Daëron M; de Araújo-Jorge TC
Infect Immun; 2005 Aug; 73(8):5048-52. PubMed ID: 16041020
[TBL] [Abstract][Full Text] [Related]
12. Trypanosoma cruzi: flow cytometric analysis of lymphocyte subsets in susceptible and protected C3H/He mice.
Powell MR; Rowland EC; Sidner RA
Exp Parasitol; 1991 Aug; 73(2):197-202. PubMed ID: 1679718
[TBL] [Abstract][Full Text] [Related]
13. CD28 is required for T cell activation and IFN-gamma production by CD4+ and CD8+ T cells in response to Trypanosoma cruzi infection.
Martins GA; Campanelli AP; Silva RB; Tadokoro CE; Russo M; Cunha FQ; Rizzo LV; Silva JS
Microbes Infect; 2004 Nov; 6(13):1133-44. PubMed ID: 15488732
[TBL] [Abstract][Full Text] [Related]
14. Non-antibody-mediated control of parasitemia in acute experimental Chagas' disease.
Trischmann TM
J Immunol; 1983 Apr; 130(4):1953-7. PubMed ID: 6403614
[TBL] [Abstract][Full Text] [Related]
15. P47phox-/- mice are compromised in expansion and activation of CD8+ T cells and susceptible to Trypanosoma cruzi infection.
Dhiman M; Garg NJ
PLoS Pathog; 2014 Dec; 10(12):e1004516. PubMed ID: 25474113
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of a trans-sialidase-ISCOMATRIX subunit vaccine candidate to protect against experimental Chagas disease.
Bontempi IA; Vicco MH; Cabrera G; Villar SR; González FB; Roggero EA; Ameloot P; Callewaert N; Pérez AR; Marcipar IS
Vaccine; 2015 Mar; 33(10):1274-83. PubMed ID: 25625671
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibodies mediating viable immunofluorescence and protection against Trypanosoma cruzi infection.
Heath AW; Martins MS; Hudson L
Trop Med Parasitol; 1990 Dec; 41(4):425-8. PubMed ID: 2127473
[TBL] [Abstract][Full Text] [Related]
18. Generation, specificity, and function of CD8+ T cells in Trypanosoma cruzi infection.
Martin D; Tarleton R
Immunol Rev; 2004 Oct; 201():304-17. PubMed ID: 15361249
[TBL] [Abstract][Full Text] [Related]
19. Effect of a combination DNA vaccine for the prevention and therapy of Trypanosoma cruzi infection in mice: role of CD4+ and CD8+ T cells.
Limon-Flores AY; Cervera-Cetina R; Tzec-Arjona JL; Ek-Macias L; Sánchez-Burgos G; Ramirez-Sierra MJ; Cruz-Chan JV; VanWynsberghe NR; Dumonteil E
Vaccine; 2010 Oct; 28(46):7414-9. PubMed ID: 20850536
[TBL] [Abstract][Full Text] [Related]
20. Changes in humoral responses to Trypanosoma cruzi during the course of infection in mice held at elevated temperature.
Dimock KA; Davis CD; Kuhn RE
J Parasitol; 1992 Aug; 78(4):687-96. PubMed ID: 1635028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
